Glenmark Pharma is recalling close to 15 lakh bottles of a generic medication used in the treatment of ADHD in the US market, the US health regulator said. The company is recalling the lot due to “CGMP deviations”, the regulator USFDA said. The recall is due to “presence of N-Nitroso Atomoxetine impurity above the FDA recommended limit,” it added. agencies
Glenmark recalls ADHD medicine bottles in US
Date:
More like thisRelated
Climate activists targeting Taylor Swift’s jet spared jail; judge says ‘actions were all about publicity’ |
Two climate activists were Monday spared jail...
Newswrap: From celebs at Satish Shah’s prayer meet to Mammootty joining hands with ‘Marco’ team |
In a heartfelt gathering, Bollywood pays tribute to...
Amitabh Bachchan treats staff to Rs 10,000 and box of sweets on Diwali; netizens react, ‘Inse jyada to Jethalal de deta hai’ |
Amitabh Bachchan's thoughtful Diwali gifts for his staff,...